Infliximab shows superior drug survival among biologics for hidradenitis suppurativa: A cohort study

被引:0
作者
Young, Albert T. [1 ]
Lu, Kathy [1 ]
Dai, Andrea [1 ]
Hamzavi, Iltefat [1 ]
Huggins, Richard [1 ]
Adrianto, Indra [1 ,2 ,3 ,4 ,5 ,6 ]
Zhou, Li [1 ,2 ,3 ,4 ,5 ,6 ]
Mi, Qing-Shen [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Henry Ford Hlth, Dept Dermatol, Cutaneous Biol & Immunol, Detroit, MI 48202 USA
[2] Henry Ford Hlth, Ctr Bioinformat, Dept Publ Hlth Sci, Detroit, MI 48202 USA
[3] Henry Ford Hlth Michigan State Univ Hlth Sci, E Lansing, MI USA
[4] Henry Ford Hlth, Henry Ford Canc Inst, Immunol Res Program, Detroit, MI 48202 USA
[5] Michigan State Univ, Coll Human Med, Dept Med, E Lansing, MI USA
[6] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI 48202 USA
基金
美国国家卫生研究院;
关键词
adalimumab; biologics; drug survival; guselkumab; hidradenitis suppurativa; infliximab; medical dermatology; secukinumab; TNF- alpha inhibitors; ustekinumab;
D O I
10.1016/j.jaad.2024.06.110
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:139 / 141
页数:3
相关论文
共 5 条
  • [1] High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa
    Ghias, Mondana H.
    Johnston, Andrew D.
    Kutner, Allison J.
    Micheletti, Robert G.
    Hosgood, H. Dean
    Cohen, Steven R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) : 1094 - 1101
  • [2] Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
    Matusiak, Lukasz
    Szczech, Justyna
    Bieniek, Andrzej
    Nowicka-Suszko, Danuta
    Szepietowski, Jacek C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) : 670 - 675
  • [3] Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study
    Prens, L. M.
    Bouwman, K.
    Aarts, P.
    Arends, S.
    van Straalen, K. R.
    Dudink, K.
    Horvath, B.
    Prens, E. P.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (01) : 177 - 184
  • [4] Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study
    Ring, Hans Christian
    Thorsen, Jonathan
    Kirby, Brian
    Ingram, John R.
    Roseno, Nana Aviaaja Lippert
    Holgersen, Nikolaj
    Nielsen, Valdemar W.
    Aagaard, David Nikolai Thein
    Maul, Julia-Tatjana
    Wu, Jashin J.
    Thyssen, Jacob P.
    Egeberg, Alexander
    Thomsen, Simon F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (05) : 769 - 771
  • [5] Drug Survival of Biologics in Patients With Hidradenitis Suppurativa
    Ring, Hans Christian
    Maul, Julia-Tatjana
    Yao, Yiqiu
    Wu, Jashin J.
    Thyssen, Jacob P.
    Thomsen, Simon F.
    Egeberg, Alexander
    [J]. JAMA DERMATOLOGY, 2022, 158 (02) : 184 - 188